Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.310
+0.010 (0.77%)
At close: Apr 1, 2026, 4:00 PM EDT
1.300
-0.010 (-0.76%)
After-hours: Apr 1, 2026, 6:09 PM EDT
Marker Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts that cover Marker Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $11.25, which forecasts a 758.78% increase in the stock price over the next year. The lowest target is $10 and the highest is $12.5.
Price Target: $11.25 (+758.78%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 8, 2025.
Analyst Ratings
The average analyst rating for Marker Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +663.36% | Dec 8, 2025 |
| WBB Securities | WBB Securities | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +854.20% | Apr 1, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +510.69% | Mar 5, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $11 → $19 | Strong Buy | Maintains | $11 → $19 | +1,350.38% | Oct 21, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +739.69% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
2.75M
from 3.55M
Decreased by -22.35%
Revenue Next Year
19.88M
from 2.75M
Increased by 621.68%
EPS This Year
-1.47
from -0.79
EPS Next Year
-0.97
from -1.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.1M | 34.5M | |||
| Avg | 2.8M | 19.9M | |||
| Low | n/a | 2.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 71.7% | 1,152.7% | |||
| Avg | -22.3% | 621.7% | |||
| Low | - | -7.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.64 | -0.20 | |||
| Avg | -1.47 | -0.97 | |||
| Low | -2.69 | -1.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.